Nearly 375,000 Bottles of Popular Antidepressant Recalled over High Levels of Carcinogen

Antidepressant recalled due to presence of potentially cancer-causing impurity

Antidepressant recalled over impurity linked to potential cancer risk.

Nearly 375,000 bottles of popular antidepressant recalled over high levels of carcinogen

The recall affects duloxetine delayed-release capsules — a generic form of the brand-name drug Cymbalta.

Hundreds of Thousands of Antidepressants Recalled Due to Cancer-Causing Chemicals.

The Food and Drug Administration has issued a Class II recall for duloxetine capsules, widely used to treat depression and anxiety, after recent tests revealed unsafe levels of cancer-causing chemicals.PULSE POINTS WHAT HAPPENED: The Food and Drug Administration (FDA) has recalled over 370,000 bottles of Cymbalta, a widely-prescribed antidepressant, over concerns that the drug may cause cancer. DETAIL: The duloxetine delayed-release capsules wer…

Commonly-Prescribed Antidepressant Recalled Over Potential Carcinogen: FDA

A commonly used prescription antidepressant medication is being recalled because it may contain a carcinogenic substance, the Food and Drug Administration announced. New Jersey-based Breckenridge Pharmaceutical, Inc., is recalling 14,729 bottles of duloxetine delayed-release capsules in 30-milligram doses, contained in 1,000-count bottles, according to a notice that was published on the FDA’s recall database this week. The medication has an expi…